Remove science ageing
article thumbnail

PING Conference 2022 – The Golden Age for Life Sciences Innovation

pharmaphorum

The PING Conference 2022 is back in person this year, with opportunities to network face-to-face with people from right across the life sciences ecosystem. Hear about how the UK is leading the way in what has been described as the ‘Golden Age for Life Sciences Innovation’ and the opportunities arising from this from leading experts.

52
article thumbnail

Has the science of anti-aging caught up with the dream of a longer life?

PharmaVoice

Billionaire investors and a new crop of longevity biotechs are betting big money on a lifespan-altering tipping point.

122
122
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Women in Science: Thermo Fisher’s Amy Butler: 'we are living in the golden age of biology'

Outsourcing Pharma

With so many advanced therapies on the horizon, the next few years are poised to be one of significant progress for patients with over 2000 cell and gene therapies in active clinical trials globally.

98
article thumbnail

Discovery that chimpanzees go through menopause challenges ‘grandmother hypothesis’

STAT

A new paper published today in Science describes the discovery of the onset of menopause in a community of wild chimpanzees around the age of 50, with an overall decline in fertility starting at age 30. Female chimps, it turns out, go through menopause, and go on to live long (and, one hopes, fulfilling) lives afterward.

142
142
article thumbnail

Bayer’s not breaking up. At least not yet

STAT

Want to stay on top of the science and politics driving biotech today?  Damian here with news of another biotech megaround, the potential next big thing from Novo Nordisk, and an anti-aging dispute involving dogs.   Sign up  to get our biotech newsletter in your inbox. Good morning, everyone. Read the rest…

87
article thumbnail

STAT+: Can investing in infectious disease pay off? Vir Biotechnology’s tightrope walk shows it’s a struggle

STAT

Nelsen, managing director of ARCH Venture, had made a name and fortune off crazy ideas, but generally it was the science that sounded crazy: engineering cells to cure cancer, finding drugs to slow aging. “This is a crazy idea,” Sato said. This new idea was financially crazy.

145
145
article thumbnail

Study: Children Infected With Mild COVID-19 May Still Develop Long Symptoms

Pharmacy Times

Investigators from University of Texas Health Science Center at Houston analyze data from individuals aged 5 to 18 years enrolled in the Texas CARES survey.

145
145